We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Bone Peptide Measurement Predicts Fracture Risk

By LabMedica International staff writers
Posted on 28 Aug 2017
Measurement of the peptide fragment that results from in vivo digestion of the periostin protein by the enzyme cathepsin K in blood samples identifies subjects at high risk of bone fracture.

Periostin is a matricellular protein involved in bone formation and bone matrix organization, but it is also produced by other tissues. More...
Its circulating levels have been weakly associated with bone microstructure and prevalent fractures, possibly because periostin measured by the current commercial assays does not specifically reflect bone metabolism.

To improve this situation, investigators at the University of Geneva (Switzerland) developed a new ELISA to measure in blood samples the concentration of the periostin fragment (K-Postn) that results from cathepsin K digestion. Cathepsin K is a protease involved in bone resorption. The enzyme's ability to catabolize elastin, collagen, and gelatin allow it to break down bone and cartilage. The investigators hypothesized that circulating K-Postn levels could be associated with bone fragility.

To test this theory, a total of 695 women (age 65.0 ± 1.5 years), enrolled in the Geneva Retirees Cohort (GERICO), were prospectively evaluated over a period of about five years for the occurrence of low-trauma fractures. The investigators measured serum periostin, K-Postn, and bone turnover markers (BTMs), distal radius and tibia microstructure by HR-pQCT (High Resolution Peripheral Quantitative Computer Tomography), hip and lumbar spine BMD (bone mineral density) by DXA (Dual-energy X-ray absorptiometry), and estimated fracture probability using the Fracture Risk Assessment Tool (FRAX).

Results revealed that 66 women sustained a low-trauma clinical fracture during the follow-up period. Total periostin was not associated with fractures; while in contrast, K-Postn was significantly higher in the fracture versus nonfracture group and associated with fracture risk. After adjustment for BMD, FRAX, bone microstructure, or BTMs, K-Postn remained significantly associated with fracture risk. Furthermore, the performance of the fracture prediction models was improved by adding K-Postn to BMD or FRAX.

Circulating K-Postn predicted risk of fracture independently of BMD, BTMs, and FRAX in postmenopausal women. Therefore, measurement of a periostin fragment resulting from in vivo cathepsin K digestion may help to identify subjects at high risk of fracture.

"The periostin fragments' strong association with incident fractures is largely independent of other bone measures, arguing that they may reflect additional bone properties related to bone quality and strength," said first author Dr. Nicolas Bonnet, a researcher in cell biology at the University of Geneva.

The study was published in the August 2, 2017, online edition of the Journal of Bone and Mineral Research.

Related Links:
University of Geneva


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
New
Slide Scanner System
NanoZoomer S540MD
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: RealTime Labs’ Mycotoxin Extensive Panel measures 31 mold-related toxins across seven toxin classes from a single urine sample (Photo courtesy of RealTime Labs)

New Urine Test Expands Mycotoxin Analysis to 31 Markers for Broader Exposure Assessment

Clinical evaluation of mold exposure increasingly relies on urinary mycotoxin testing, but limited marker coverage and metabolite masking can make results more difficult to interpret. Broader analysis... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Collaboration combines cognitive assessment, blood testing, phlebotomy, and MRI to support faster diagnosis across the UK (Image Credt: Adobe Stock)

New UK Collaboration Expands Access to Integrated Alzheimer’s Diagnostic Testing

C2N Diagnostics and Cambridge Cognition have partnered with The Alzheimer’s Trust to create an integrated pathway aimed at supporting earlier and more accurate diagnosis of Alzheimer’s disease and related dementias.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.